Skip to main content

Table 1 Clinical characteristics of patients with bladder cancer who underwent radical cystectomy with TIVA-TCI or BAL anesthesia

From: Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical Cystectomy: preliminary results

 

All cancer patients (n. 28)

TIVA-TCI (n. 14)

BAL (n. 14)

P TIVA-TCI vs. BAL

Age (yrs)

62.04 ± 8.63

63.2 ± 6.8

61.2 ± 10.8

0.57

Sex , n (%)

    

 males

23 (82.1%)

12 (85.7%)

11 (78.6%)

0.62

 females

5 (17.9%)

2 (14.3%)

3 (21.4%)

 

Histological type of cancer

    

 High grade urothelial carcinoma

28 (100%)

14 (100%)

14 (100%)

1.00

pT, n (%)

    

 1-2

11 (39.3%)

6 (42.9%)

5 (35.7%)

0.70

 3

17 (60.7%)

8 (57.1%)

9 (64.3%)

 

pN, n (%)

    

 0

22 (78.6%)

12 (85.7%)

10 (71.4%)

0.34

 1

2 (7.1%)

0

2 (14.3%)

 

 2

4 (14.3%)

2 (14.3%)

2 (14.3%)

 

ASA, n (%):

    

 I-II

18 (64.3%)

9 (64.3%)

9 (64.3%)

1.00

 III

10 (35.7%)

5 (35.7%)

5 (35.7%)

 

Weight (BMI )

25.8 ± 4.2

27.1 ± 5.9

25.1 ± 3.0

0.55

Time of surgery (h)

3.12 ± 0.59

3.08 ± 0.58

3.17 ± 0.56

0.27

Time of anaesthesia (h)

3.27 ± 0.48

3.18 ± 0.45

3.35 ± 0.51

0.42

Time of hospitalization (days)

13.29 ± 1.00

13.58 ± 0.99

13.00 ± 0.95

0.16

Metastasis after surgery, n (%)

4 (14.3%)

1 (7.1%)

3 (21.4%)

0.28

Death from cancer, n (%)

5 (17.9%)

1 (7.1%)

4 (28.6%)

0.14

Death from any cause, n (%)

7 (25.0%)

2 (14.3%)

5 (35.7%)

0.19

  1. Values are expressed in absolute values or mean ± SD.